Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Biocon | NSE | Healthcare | Biotechnology & Medical Research | ₹398.60B | 50x | -1.5 | ₹333.40 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19.9% Upside | Upgrade to Pro+ | |
Biocon | BSE | Healthcare | Biotechnology & Medical Research | ₹386.63B | 48.1x | -1.5 | ₹322.90 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.9% Upside | Upgrade to Pro+ | |
Syngene International Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹269.48B | 54.8x | ₹671.80 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.5% Upside | Upgrade to Pro+ | ||
Syngene International Ltd BO | BSE | Healthcare | Biotechnology & Medical Research | ₹267.33B | 53.5x | ₹666 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Suven Life Sciences | BSE | Healthcare | Biotechnology & Medical Research | ₹26.47B | -17.8x | 0.55 | ₹121.55 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Suven Life Sciences Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹26.47B | -17.8x | 0.55 | ₹121.42 | 7.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Shree Ganesh Remedies | BSE | Healthcare | Biotechnology & Medical Research | ₹8.43B | 29.6x | 1.18 | ₹657.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Indo Us Bio-Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹3.29B | 25.1x | 0.43 | ₹163.95 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions | BSE | Healthcare | Biotechnology & Medical Research | ₹1.27B | -1.9x | 0.32 | ₹8.77 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Take Solutions Ltd | NSE | Healthcare | Biotechnology & Medical Research | ₹1.27B | -1.9x | 0.32 | ₹8.68 | -3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jeevan Scientific Technology | BSE | Healthcare | Biotechnology & Medical Research | ₹665.03M | 101.9x | 0.84 | ₹42 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vivo Bio Tech | BSE | Healthcare | Biotechnology & Medical Research | ₹573.21M | 7.6x | 0.15 | ₹35.54 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Transgene Biotek | BSE | Healthcare | Biotechnology & Medical Research | ₹288.68M | -122.9x | -1.52 | ₹3.81 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vanta Bioscience | BSE | Healthcare | Biotechnology & Medical Research | ₹194.09M | -5x | -0.36 | ₹30.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |